A bipartisan group of senators is resurfacing legislation to cap many American patients’ insulin costs at $35 a month — the INSULIN Act of 2026 — reviving a push that previously stalled.The bill co-authored by Sens. Jeanne Shaheen, D-N.H., Susan Collins, R-Maine, Raphael Warnock, D-Ga., and John Kennedy, R-La., would bar group and individual health plans from imposing deductibles on selected insulin products and could not charge more than $35 for a 30-day supply starting in plan year 2027.Beginning in 2028, patients would pay the lesser of $35 or 25% of the negotiated net price.Congress had al...
HALO NEWSLETTER
Join HALO today and unlock this story instantly — It's Free
